In the latest annual scientific sessions at the ACC 24, the results from the REDUCE AMI trial have put the spotlight back on beta blockers, the age-old drug which has conventionally been used to treat post acute coronary syndrome patients. This registry-based randomized clinical trial, conducted among 5020 subjects, 95% of them being Swedish, led…